One in 5 older adults used cannabis products that include THC in the last year. Among them, 20% said they drove within 2 hours of using cannabis, and a similar percentage said they experience at least one potential signs of addiction.
Scientists have identified a crucial gene, CsMIKC1,that controls the number of flowering sites in Cannabis sativa, a finding that could significantly enhance both medicinal and grain yields. The study reveals how CsMIKC1 drives inflorescence development, offering new pathways to boost productivity in Cannabis cultivation.
Marijuana use is common among patients considering plastic surgery and is associated with elevated nicotine levels on laboratory tests, reports a paper in the September issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The journal is published in the Lippincott portfolio by Wolters Kluwer.
A cutting-edge study reveals the natural compound (-)-carvone in Spearmint as a potent and sustainable alternative to chemical herbicides. This research demonstrates how (-)-carvone targets and degrades microtubules in weeds, inducing cell death and inhibiting growth without harming the environment. The findings suggest a future where allelopathic plants offer eco-friendly solutions to weed management, supporting biodiversity and reducing the reliance on harmful chemicals in agriculture.
A study from the USC Head and Neck Center, part of Keck Medicine of USC and the USC Caruso Department of Otolaryngology – Head and Neck Surgery, suggests that cannabis, the most commonly used illicit substance worldwide, is associated with an increased occurrence of head and neck cancer.
Breaking research shows that rates of cannabis use during pregnancy are far higher than previously thought, a finding that could improve efforts to identify pregnant cannabis users and inform them of potential risks.
In research published in Nature Mental Health this month, researchers at Washington University in St. Louis outline the intermediate biological steps that could play into how prenatal cannabis exposure leads to behavioral issues down the line.
Loosening local, state and federal regulations on cannabis and psychedelics has increased Americans' interest in microdosing, according to a study from researchers at the University of California San Diego.
Theoretical models of alcohol and cannabis use disorders often focus on the idea that people consume alcohol and cannabis use to regulate their negative emotions – in other words, to make themselves feel better. New research does not support this idea, finding instead that people mostly consume alcohol and cannabis in their daily life when they are experiencing positive emotions.
A study by researchers at Washington University School of Medicine in St. Louis shows that people with COVID-19 who used cannabis were more likely to be hospitalized and require intensive care than those who did not use the drug.
Nearly one in six patients in primary care reported cannabis use, with 35% of those using at levels indicating moderate- to high-risk use disorder. The findings indicate the need for routine cannabis use screening. Currently few healthcare systems offer this screening in primary care settings.
A new study by researchers at the Case Western Reserve University School of Medicine reveals that the popular diabetes and weight-loss drugs Wegovy and Ozempic are linked to reduced incidence and recurrence of alcohol abuse or dependence.
A University of Miami cannabis epidemiologist and a criminal law specialist applaud the federal government’s proposal to reverse the criminalization of cannabis.
Researchers at UC San Diego have found that nearly 3% of healthy adolescents use commercial CBD products, many of which contain higher levels of THC than advertised.
The proposed reclassification of marijuana, or cannabis, by the U.S. Drug Enforcement Administration makes MSU researchers both optimistic and pessimistic.
In women of childbearing age, cannabis use may increase the risk of adverse reproductive and perinatal health outcomes. A study in a sample of 20,234 women ages 18 to 49 by disability status showed that about 60% of women with disabilities who used cannabis in the past 12 months perceived no risk of harm from weekly cannabis use.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
